121 related articles for article (PubMed ID: 21653951)
21. Global perspectives on vaccine financing.
Berman S; Giffin RB
Expert Rev Vaccines; 2004 Oct; 3(5):557-62. PubMed ID: 15485335
[TBL] [Abstract][Full Text] [Related]
22. Projecting the health and economic impact of road safety initiatives: a case study of a multi-country project.
Esperato A; Bishai D; Hyder AA
Traffic Inj Prev; 2012; 13 Suppl 1():82-9. PubMed ID: 22414132
[TBL] [Abstract][Full Text] [Related]
23. Global support for new vaccine implementation in middle-income countries.
Kaddar M; Schmitt S; Makinen M; Milstien J
Vaccine; 2013 Apr; 31 Suppl 2():B81-96. PubMed ID: 23598496
[TBL] [Abstract][Full Text] [Related]
24. Establishing the health and economic impact of influenza vaccination within the European Union 25 countries.
Ryan J; Zoellner Y; Gradl B; Palache B; Medema J
Vaccine; 2006 Nov; 24(47-48):6812-22. PubMed ID: 17034909
[TBL] [Abstract][Full Text] [Related]
25. Values for preventing influenza-related morbidity and vaccine adverse events in children.
Prosser LA; Bridges CB; Uyeki TM; Rêgo VH; Ray GT; Meltzer MI; Schwartz B; Thompson WW; Fukuda K; Lieu TA
Health Qual Life Outcomes; 2005 Mar; 3():18. PubMed ID: 15780143
[TBL] [Abstract][Full Text] [Related]
26. Vaccine supply chains need to be better funded and strengthened, or lives will be at risk.
Kaufmann JR; Miller R; Cheyne J
Health Aff (Millwood); 2011 Jun; 30(6):1113-21. PubMed ID: 21653965
[TBL] [Abstract][Full Text] [Related]
27. Financial requirements of immunisation programmes in developing countries: a 2004-2014 perspective.
Peny JM; Gleizes O; Covilard JP
Vaccine; 2005 Aug; 23(37):4610-8. PubMed ID: 15979769
[TBL] [Abstract][Full Text] [Related]
28. Conquering the intolerable burden of malaria: what's new, what's needed: a summary.
Breman JG; Alilio MS; Mills A
Am J Trop Med Hyg; 2004 Aug; 71(2 Suppl):1-15. PubMed ID: 15331814
[TBL] [Abstract][Full Text] [Related]
29. New vaccines against otitis media: projected benefits and cost-effectiveness.
O'Brien MA; Prosser LA; Paradise JL; Ray GT; Kulldorff M; Kurs-Lasky M; Hinrichsen VL; Mehta J; Colborn DK; Lieu TA
Pediatrics; 2009 Jun; 123(6):1452-63. PubMed ID: 19482754
[TBL] [Abstract][Full Text] [Related]
30. India's vaccine deficit: why more than half of Indian children are not fully immunized, and what can--and should--be done.
Laxminarayan R; Ganguly NK
Health Aff (Millwood); 2011 Jun; 30(6):1096-103. PubMed ID: 21653963
[TBL] [Abstract][Full Text] [Related]
31. Overcoming economic barriers to the optimal use of vaccines.
Lieu TA; McGuire TG; Hinman AR
Health Aff (Millwood); 2005; 24(3):666-79. PubMed ID: 15886158
[TBL] [Abstract][Full Text] [Related]
32. Vanishing vaccinations: why are so many Americans opting out of vaccinating their children?
Calandrillo SP
Univ Mich J Law Reform; 2004; 37(2):353-440. PubMed ID: 15568260
[TBL] [Abstract][Full Text] [Related]
33. Apropos "New vaccines for developing countries: will it be feast or famine"?
Arya SC; Agarwal N
Am J Law Med; 2009; 35(4):691. PubMed ID: 20196288
[No Abstract] [Full Text] [Related]
34. Population growth. Its magnitude and implications for development.
Birdsall N
Finance Dev; 1984 Sep; 21(3):10-5. PubMed ID: 12266357
[TBL] [Abstract][Full Text] [Related]
35. Retrospective cost-effectiveness analyses for polio vaccination in the United States.
Thompson KM; Tebbens RJ
Risk Anal; 2006 Dec; 26(6):1423-40. PubMed ID: 17184390
[TBL] [Abstract][Full Text] [Related]
36. The epidemiology of measles.
Clements CJ; Strassburg M; Cutts FT; Torel C
World Health Stat Q; 1992; 45(2-3):285-91. PubMed ID: 1462663
[TBL] [Abstract][Full Text] [Related]
37. Motor vehicle safety, health care, and taxes. National Highway Traffic Safety Administration, U.S. Department of Transportation.
Prehosp Disaster Med; 1994; 9(1):11-23. PubMed ID: 10155483
[TBL] [Abstract][Full Text] [Related]
38. Broadening the age restriction for initiating rotavirus vaccination in regions with high rotavirus mortality: benefits of mortality reduction versus risk of fatal intussusception.
Patel MM; Clark AD; Glass RI; Greenberg H; Tate J; Santosham M; Sanderson CF; Steele D; Cortese M; Parashar UD
Vaccine; 2009 May; 27(22):2916-22. PubMed ID: 19428901
[TBL] [Abstract][Full Text] [Related]
39. Distributional impact of rotavirus vaccination in 25 GAVI countries: estimating disparities in benefits and cost-effectiveness.
Rheingans R; Atherly D; Anderson J
Vaccine; 2012 Apr; 30 Suppl 1():A15-23. PubMed ID: 22520124
[TBL] [Abstract][Full Text] [Related]
40. Projected health and economic impact of rotavirus vaccination in GAVI-eligible countries: 2011-2030.
Atherly DE; Lewis KD; Tate J; Parashar UD; Rheingans RD
Vaccine; 2012 Apr; 30 Suppl 1():A7-14. PubMed ID: 22520139
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
